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Fusarium culmorum is a fungal pathogen causing economically important diseases on
a variety of crops. Fungicides can be applied to control this species with triazoles being
the most efficient molecules. F. culmorum strains resistant to these molecules have been
reported, but the underlying resistance mechanisms remain unknown. In this study, a
tebuconazole-adapted F. culmorum strain was developed with a level of fitness similar
to its parental strain. The adapted strain showed cross-resistance to all demethylation
inhibitors (DMIs), but not to other classes of fungicides tested. RNA-Seq analysis
revealed high transcriptomic differences between the resistant strain and its parental
strain after tebuconazole treatment. Among these changes, FcABC1 (FCUL_06717),
a pleiotropic drug resistance transporter, had a 30-fold higher expression level upon
tebuconazole treatment in the adapted strains as compared to the wild-type strain. The
implication of this transporter in triazole resistance was subsequently confirmed in field
strains harboring distinct levels of sensitivity to triazoles. FcABC1 is present in other
species/genera, including F. graminearum in which it is known to be necessary for azole
resistance. No difference in FcABC1 sequences, including the surrounding regions, were
found when comparing the resistant strain to the wild-type strain. Fusarium culmorum
is therefore capable to adapt to triazole pressure by overexpressing a drug resistance
transporter when submitted to triazoles and the same mechanism is anticipated to occur
in other species.
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INTRODUCTION
Fusarium culmorum ([W.G. Smith] Saccardo) is a fungal
pathogen responsible for multiple diseases on a variety of crops
and weeds. Among these diseases, Fusarium head blight (FHB)
is one of the major small-grain cereal diseases. It is caused by a
complex of species belonging to the Fusarium andMicrodochium
genera that can infect the ear (Parry et al., 1995). Fusarium spp.
are the species of most concern because, in addition to yield
losses, they can produce a wide range of mycotoxins (Desjardins,
2006). Fusarium culmorum and F. graminearum (Schwabe), a
closely related species, are among the most common species
found in Europe, but with high variations between years and
locations (Parry et al., 1995; Xu et al., 2005; Hellin et al.,
2016a). These species can produce the type B trichothecenes
deoxynivalenol (DON) or nivalenol (NIV), depending on the
strain. Type B trichothecenes were shown to contribute to
virulence on wheat and were demonstrated to inhibit protein
translation threatening human and animal health (Desjardins,
2006).
Triazoles are the most widely used fungicides in managing
FHB because of their greater efficacy compared with other active
ingredients (Mesterházy, 2003). As demethylation inhibitors
(DMIs), they prevent fungal growth by specifically binding to the
14α-demethylase (CYP51), an essential enzyme for completing
the synthesis of ergosterol (Ziogas and Malandrakis, 2015).
Resistance levels to triazoles of F. graminearum populations have
been shown to have gradually increased since their introduction
into the market (Klix et al., 2007; Sun et al., 2014), and
resistant strains of F. graminearum have also been reported
in China and the US (Yin et al., 2009; Spolti et al., 2014).
In addition, prolonged laboratory exposure to triazoles caused
the adaptation of Fusarium spp. resulting in the appearance of
resistant phenotypes (Becher et al., 2010; Serfling and Ordon,
2014). Although high variations in sensitivity have been noted
among strains of F. culmorum, no decline of sensitivity has been
observed over time, probably because of a fitness cost associated
with the resistance (Hellin et al., 2016b).
In various fungi, an increase in fungicide resistance has been
achieved by: (1) target gene duplication; (2) mutation of the
target protein; (3) overexpression of the target gene; (4) fungicide
detoxification or; (5) fungicide export by transporters (Lucas
et al., 2015; Ziogas and Malandrakis, 2015). The molecular
mechanisms involved in resistance to triazoles in Fusarium spp.
are still unknown and are mostly investigated in F. graminearum.
The genome of this species has revealed the presence of three
paralogous copies of the CYP51 gene, among which CYP51Aand
CYP51B, are thought to be involved in triazole sensitivity (Liu
et al., 2011; Fan et al., 2013; Qian et al., 2018). Laboratory directed
mutation Y137H in F. graminearum CYP51B resulted in reduced
sensitivity to tebuconazole (Qian et al., 2018). Nevertheless,
neither mutation nor overexpression of those gene, has been
related to a change in azole sensitivity in F. graminearum (Yin
et al., 2009; Talas and McDonald, 2015). Transporters from
the ATP-binding cassette (ABC) family are known for their
implication in drug resistance in multiple fungi (Ziogas and
Malandrakis, 2015) and Fusarium graminearum possesses 62
potential ABC transporters (King et al., 2015). The function of
four of them has been investigated through gene deletion, and
FgABC3 (FGSG_04850) has been shown to be essential for azole
resistance (Abou Ammar et al., 2013). Moreover, a homologous
copy of this gene (FcABC1) has been previously found to be
necessary for full virulence in F. culmorum (Skov et al., 2004).
The use of “omics” analysis for the determination of resistance
mechanisms is gaining interest and it is anticipated to play a
big role in the future fungicide development and registration
procedures (Cools and Hammond-Kosack, 2013). For example,
genome-wide transcriptomic analysis were used to establish
F. graminearum response to azole treatment and revealed the
overexpression of multiple genes, including transporters (Liu
et al., 2010; Becher et al., 2011). In other fungal species,
comparison of the transcriptomic response to azole of strains
with different levels of sensitivity allowed the identification of
transporters for which the level of expression could be linked to
resistance (Hulvey et al., 2012; Omrane et al., 2015; Sang et al.,
2015). The recent publication of the first annotated version of
the F. culmorum strain UK99 (Urban et al., 2016) provides a
new tool to investigate triazole resistance mechanisms in this
agro-economically important species.
In this study, we adapted the sensitive F. culmorum UK99
strain to tebuconazole in vitro and compared its transcriptome
with that of its parental strain when subjected to this fungicide.
By using strains that shared the same genetic background,
the differences detected could be directly attributed to DMI
adaptation and were verified on a set of field strains harboring
distinct levels of triazole sensitivity.
MATERIALS AND METHODS
Strains and Preservation
Fusarium culmorum strain UK99 (syn. NRRL 54111 and FGSC
10436) was used as the reference strain in this study. Six other F.
culmorum strains, either sensitive (MBC 7964, MBC 6020, and
MBC 7603) or more resistant (MBC 190, MBC 7555 and CRA-
PAV ER 1998) to triazoles, as previously characterized (Hellin
et al., 2016b), were used as field controls. All strains were stored
in 20% glycerol at−80◦C.
Adaptation of Fusarium culmorum to
Tebuconazole
Fusarium culmorum strain UK99 was adapted to tebuconazole
following the protocol described by Becher et al. (2010), with
slight modifications. In brief, three plugs (5mm diameter)
from UK99 cultured on potato dextrose agar (PDA; Oxoid,
Waltham, MA, USA) were used to inoculate 100mL of potato
dextrose broth (PDB; Becton Dickinson, Franklin Lakes, NJ,
USA) cultured in the dark at 22◦C (100 rpm). After 3 days, the
media were replaced by fresh PDB amended with 0.4 mg/L of
tebuconazole (Pestanal; Sigma Aldrich, Saint-Louis, MI, USA)
dissolved in ethanol. After 11 days, the media were replaced
again with fresh PDB amended with 1 mg/L and 11 days later
with PDB containing 10 mg/L of tebuconazole. Mock cultures
were supplied at the same time, with fresh PDB supplemented
with the same volume of ethanol (1%). The mycelia produced
Frontiers in Microbiology | www.frontiersin.org 2 June 2018 | Volume 9 | Article 1385
Hellin et al. FcABC1 Is Associated With Azole Resistance
were harvested by centrifugation (3,000 rpm for 10min) and
homogenized in twice their volume of 20% glycerol with a Sorvall
Omni-Mixer (DuPont Instruments, Wilmington, DE, USA) at
half speed for 10 s. Conidia were produced by inoculating 100 µL
of each culture in mung bean broth (MBB, 40 g of mung beans
per liter) and cultivated at 22◦C with a 12 h alternation of light
and darkness for 7 days (50 rpm). These suspensions were
serially diluted and spread onto PDA plates supplemented with
10 mg/L of tebuconazole and incubated at 22◦C. Colonies that
subsequently grew were transferred to new PDA plates. Single
conidium strains were then produced and cultured in MBB
to produce the first generation of adapted strains. Each strain
was cultivated on PDA for 5 days and then a new PDA plate
was inoculated with a plug originating from the margin of the
colony. This last procedure was repeated six times to produce a
seventh generation that was used to test the mitotic stability of
the fungicide resistance acquired by the strain.
Assessment Fitness Parameters and
Pathogenicity
A rapid screening procedure of the adapted phenotypes of
the first generation was carried out in order to find a
suitable candidate strain comparable with the parental strain
(UK99). A preliminary test compared growth rate, sporulation
and pathogenicity to wheat of the strains, as explained
hereafter. Fitness parameters of the wild-type strain (UK99)
and the selected tebuconazole-adapted strain (P1P2) of the first
generation were then more thoroughly assessed by other assays.
The growth rate of each strain was determined by measuring
colony radius after 4 days on PDA medium inoculated with
a 5mm plug excised from the margin of a 7-day-old culture.
Experiments were performed at 10, 22, and 30◦C with three
plates per condition and two biological replicate. Sporulation
capacity was determined by measuring the conidia concentration
obtained in MBB, as explained above, with four replicates and
two biological repeats.
In order to assess the pathogenicity of strains toward wheat
seedlings (cv Homeros), disinfected seeds (5min in 1% NaOCl,
rinsed twice in sterile water for 2min and dried on filter paper)
were deposited in test tubes filled with 6mL of 1.5% water agar
(1 seed/tube). The tubes were kept in the dark for 3 days to allow
germination and then inoculated with a mycelial plug (5mm).
Uncolonized PDA plugs were used for mock controls. The length
of the plantlets was measured at 4 and 11 days post-inoculation
and growth rate retardation was calculated with regard to control
plantlets. Two replications of 10 plantlets per strain were used.
Wheat seeds of the spring cv Triso were sown in 20 cm pots
(2 seeds/pot) filled with a mixture containing equal parts of
local agricultural soil, sand and potting mix. The plants were
grown in a greenhouse and inoculated as described by Fernandez
and Chen (2005). Half of the plants were then treated with
tebuconazole (Horizon, Bayer) using a hand sprayer (1.25 L
Comfort 814; Gardena, Ulm, Germany). The concentration of
the active ingredient in the mixture in order to achieve the
recommended spraying rate of 1 L/Ha was initially estimated to
be 0.25 mg/mL. After 14 days, ear surface presenting bleached
symptoms on were evaluated. Fourteen ears were scored per
modality.
The pathogenicity to maize seedlings of strains UK99 and the
selected strain P1P2 was assessed on the maize hybrid “Troizi
CS.” Ten-day-old cultures on Corn Meal Agar (CMA; corn grits
[200 g/L] and agar [20 g/L]) were blended and incorporated in
500mL of a sterile mixture of potting mix and sand (2:1). Two
culture plates were used per 20 cm pot. After 3 days of incubation,
10 grains of maize (surface sterilized as previously explained)
were sown in each pot and cultivated in the greenhouse (20◦C).
Seedling length was measured after 15 days and compared with
the controls.
The same maize cultivar was used to compare the
pathogenicity of both strains toward maize stalks using
toothpick inoculation assays, as described by Scauflaire et al.
(2012), with nine plants per modality. Necrotic areas observed in
longitudinal cross section were measured with ImageJ software
v. 1.48 (Schneider et al., 2012) and the mean area of the controls
was subtracted from the ones of the inoculated stem sample.
Quantitative and Qualitative Determination
of Fungicide Sensitivity
The sensitivity of the first and seventh generations of UK99
and P1P2 to tebuconazole (Horizon, Bayer) was assessed using
a microtiter plate assay (Hellin et al., 2016b) to quantify the
increase in triazole resistance acquired through the adaptation
procedure. In order to test for cross-resistance with other classes
of fungicides, about 250 conidia (2 µL of a 1.25 × 105 conidia
m/L spore suspension) were point inoculated onto PDA plates
amended with fungicide at concentrations preliminary estimated
to inhibit UK99 growth by about 80-95%. The fungicides used
for comparison were tebuconazole (1 mg/L; Horizon, Bayer),
epoxiconazole (1 mg/L; Opus, BASF), cyproconazole (10 mg/L;
Caddy, Bayer), Bayer), tetraconazole (10 mg/L; Eminent, Isagro),
propiconazole (1 mg/L; Tilt, Syngenta), difenoconazole (1 mg/L;
Score, Syngenta), prothioconazole (10 mg/L; Proline, prochloraz
(0.1 mg/L; Sportak, BASF), imazalil (1 mg/L; Fungaflor, Certis
Europe), fenarimol (10 mg/L; Rubigan 40, Dow), carbendazim (1
mg/L; Bavistin, BASF), thiabendazole (1 mg/L; Tecto, Syngenta),
pyrimethanil (100 mg/L; Scala, BASF), and fenpropimorh (100
mg/L; Corbel, BASF). The fungicides were dissolved in ethanol,
apart from Opus, Tecto and Bavistin, which were dissolved
in water because of their commercial formulation. The plates
were incubated in the dark at 22◦C for 7 days. Both sensitivity
tests contained triplicates and were repeated twice. Azoxystrobin
(Amistar, BASF), boscalid (Cantus, BASF) and bixafen (Pestanal;
Sigma Aldrich) were omitted from the test because the maximum
growth reduction obtained with 100 mg/L of these fungicides on
UK99 was only 61, 22, and 65%, respectively.
RNA Isolation and RT-qPCR
For each strains, 106 conidia were used to inoculate 100mL
of liquid complete medium (CM, Correll et al., 1987). The
cultures were incubated in the dark (22◦C, 120 rpm) for
24 h before being supplemented with 0.5mL of tebuconazole
(Pestanal; Sigma-Aldrich) dissolved in ethanol to reach a
concentration of 2.5 mg/L. The same amount of ethanol was
Frontiers in Microbiology | www.frontiersin.org 3 June 2018 | Volume 9 | Article 1385
Hellin et al. FcABC1 Is Associated With Azole Resistance
added to the control cultures. After 12 h, myceliumwas harvested
from each culture (three per condition) in Miracloth and
quickly washed with sterile water before being flash frozen in
liquid nitrogen and ground with a mortar and pestle. RNA
extraction was performed on 100mg of sample using RNeasy
Plant mini kit (Qiagen, Hilden, Germany) combined with
the RNase-free DNase set (Qiagen). Total RNA was reverse-
transcribed with M-MLV Reverse Transcriptase kit (Promega,
Madison, WI, USA) using a cocktail of anchored oligo(dT)25.
Quantitative PCRs were performed using Takyon No Rox
SYBR MasterMix dTTP Blue reactive (Eurogenetec, Seraing,
Belgium) in CFX96 thermal cycler (BioRad, Hercules, CA,
USA). The expression of two genes coding for predicted cofilin
and pre-mRNA splicing factor and known for their stability
in F. graminearum under fungicide stress (FGSG_06245 and
FGSG_01244, respectively; Becher et al., 2011) were used as
housekeeping genes. Normalization of expression was performed
by the 2−1Ct method implemented in CFX manager software
(BioRad). All primer pairs were obtained using primer-BLAST
and were designed so that one primer would span an exon
junction, when it was possible (Table S5). Standard PCR and
gel electrophoresis were performed to verify the presence of a
single amplicon after amplification of cDNA samples and the
absence of genomic amplification on total RNA extracts. For each
primer pair, the amplification product was purified using MSB
spin PCRapace (Startec Biomedical AG, Birkenfeld, Germany)
and sequenced to confirm target specificity (Macrogen Europe,
Amsterdam, The Netherlands).
Library Preparation and Sequencing
Samples of total RNA belonging to tebuconazole-treated cultures
of UK99 and P1P2 (three replicates per strain) were sent to
Beckman Coulter Genomics facility (Danvers, MA, USA). Total
RNA quantity and quality were determined with a Quant-iT RNA
assay kit (Invitrogen, Carlsbad, CA, USA) and a TapeStation
(Agilent Technologies, Santa Clara, CA, USA), respectively. The
six libraries were prepared using TruSeq RNA Library Prep
Kit v2 (Illumina, San Diego, CA, USA) on a Biomek FXP
liquid handling platform (Beckman Coulter, Brea, CA, USA).
Qualitative and quantitative evaluation of the content of each
library was performed using the KAPA library quantification
kit for Illumina platform (Kapa Biosystems, Boston, MA, USA)
and a Tapestation, respectively. Libraries were then diluted to 25
pM, pooled and sequenced (2 × 125 pb) on Illumina HiSeq2500
platform (high output mode) using V4 reagents. The quality of
sequencing was assessed using FastQC (Andrews, 2016).
Transcriptome Analysis
Hisat2 (Pertea et al., 2016) was used to map the reads to F.
culmorum UK99 genome (Accession No. PRJEB12835; Urban
et al., 2016) with default settings and using the genome
annotation (http://pre.fungi.ensembl.org). No pre-processing
of the reads took place. Cuffdiff v2.2.1 (Trapnell et al.,
2013) was used determine the abundance of transcripts in
FPKM (Fragments Per Kilobase per Million mapped reads). A
differential testing of counts (P1P2 vs. UK99) was performed
with Cuffdiff with a classic FPKM library normalization method,
pooled dispersion estimation method, and bias correction with
effective length, counting against the UK99 gene annotation only.
Annotations were added to the Cuffdiff output using Blast2go
v3.3.5 (Conesa et al., 2005) with the Blast2go GO database
(05/2016) and default filtering settings, using input from Interpro
(v58.0) and DeCypher (Timelogic, USA, CA, Carslbad) with the
NCBI NR database (23/06/16) using an e-value threshold of 1e-
2. SNP calling was performed with FreeBayes (version 1.0.2.29)
using default settings, filtering forminimum coverage of 10 reads.
SNP effects were predicted using snpEff (4.0). Heterozygous
SNPs were considered as low frequency variant and were not
further analyzed. Data were compared to that of a microarray
study comparing the transcriptome of F. graminearum PH-1
with or without tebuconazole application (Becher et al., 2011;
E-GEOD-25114).
Sequencing of FcABC1
DNA of F. culmorum strains was extracted from 100mg
of ground mycelia using DNeasy Plant Mini kit (Qiagen).
Primers for sequencing of gene FcABC1 and its flanking
regions were designed with primer-Blast (Table S6). Two
fragments corresponding to the upstream region (about 1,000
bp from the start codon) and the ORF + partial 3′ UTR region
(about 5,000 bp) were amplified using Phusion High-Fidelity
DNA Polymerase (Thermo Scientific, Waltham, MA, USA)
following the manufacturer’s instructions. Amplicons were
purified with MSB spin PCRapace kit (Startec Biomedical
AG) and sequenced by Macrogen using the amplification
primers. Six intermediate primers were used for sequencing
the ORF + 3′ UTR region because of its extensive length
(Table S6). Only the promoter region was amplified for
F. culmorum field isolates. Sequences were assembled and
contigs were subsequently edited with Sequencher 4.8
(Gene Codes Corp., Ann Arbor, MI, USA). After alignment
with MUSCLE, DNA sequence of UK99 was compared
manually to the ones of P1P2, F. culmorum CS7071 (NCBI
Accession No. CBMH000000000; Moolhuijzen et al. 2013),
F. graminearum PH-1 (FGSG_04850 = FgABC3) and F.
pseudograminearum CS3096 (FSPE_06011; Moolhuijzen et al.,
2013).
Statistical Analysis of Fitness Parameters
and RT-qPCR
Comparisons of fitness parameters between P1P2 and UK99 were
analyzed using t-tests or two-way ANOVA (depending on the
number of factors) in JMP R© PRO 12 (SAS Institute Inc., Cary,
NC, USA). EC50 values were determined using logistic regression
as described by Hellin et al. (2016b) and compared among strains
and generations by a two-way ANOVA. Quantitative real-time
PCR results between P1P2 and UK99 were compared using two-
way ANOVA. Differences in expression of selected genes in
sensitive and resistant field strains were analyzed using linear
mixed models with the “strain” set as a random factor. Whenever
the interaction parameter was significant, Tukey’s HSD test was
performed.
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RESULTS
Fusarium culmorum Is Able to Adapt to
Tebuconazole Without Losing Its
Competitiveness
After 35 days, the cultivation of F. culmorum strain UK99
in liquid broth, supplemented with periodically-increasing
concentrations of tebuconazole, yielded multiple resistant
colonies, which subsequently grew on potato dextrose agar
amended with tebuconazole (10 mg/L). The strain P1P2 was
selected for its characteristics similar to those of the wild-type
strain (Figure S1). The resemblance of both strains was further
investigated with multiple assays (Figure 1). After 4 days of
incubation on PDA, although temperature had a significant
impact on strain growth (P < 0.001, Figure 1A), the radius of
both strains were similar (P = 0.533). Sporulation capacity of the
adapted strain also remained unchanged (P = 0.355, Figure 1B).
Both strains were found to be equally aggressive to both wheat
and maize. They produced similar discoloration on wheat ears,
with symptoms covering an average surface of 20% of the spikes
(P = 0.535, Figure 1C). A tebuconazole treatment applied 2 days
after inoculation resulted in the symptoms being reduced by half
(P = 0.037), but no significant difference was observed between
strains (P = 0.535), although P1P2 seemed to be a little more
competitive than UK99 on treated ears (Figure 1C). Growth rate
of the wheat plantlets, measured between 4 and 11 days after
inoculation, was reduced in a similar way by both strains, with an
average of 72% reduction (P= 0.846, Figure 1D). Maize seedling
growth after 15 days was reduced by an average of 40% by both
strains (P = 0.287; Figure 1E) when the seeds were sown in
infected soil. In maize stalk infection assays, the average surface
of necrotic lesions produced by both strains was also similar
(P = 0.391).
The Adapted Strain Is More Resistant to
DMI Fungicides Than the Wild-Type Strain
Strain P1P2 was found to be significantly more resistant than
UK99 (P < 0.001, Figure 2). The EC50 value for P1P2 (3.63
mg/L ± 0.3) was found to be about 10-fold greater than for
UK99 (0.37 mg/L ± 0.001). The acquisition of tebuconazole
resistance was stable over time given that the sensitivity of the
seventh generation (EC50 = 2.93 mg/L ± 0.53 and 0.37 mg/L
± 0.006 for P1P2 and UK99, respectively; P = 0.088) did not
significantly differ from the first. Cross-resistance was observed
for all the tested DMIs (triazoles: tebuconazole, epoxiconazole,
propiconazole, difenoconazole, tetraconazole and cyproconazole;
triazolinthiones: prothioconazole; imidazoles: prochloraz and
imazalil; pyrimidines: fenarimol), with P1P2 being able
to develop on PDA media supplemented with fungicide
concentrations highly inhibitory to UK99 growth (Figure 3).
No differences were observed between strains when cultivated
on media containing benzimidazoles (carbendazim and
thiabendazole) or morpholine (fenpropimorph). Interestingly,
the anilino-pyrimidine fungicide tested (pyrimethanil) showed
a weaker efficacy on the parental strain than on the adapted
strain.
Transcriptome Analysis Revealed Major
Differential Expression Between the
Treated Parental and Adapted Strains
The transcriptome sequencing of tebuconazole-treated strains
UK99 and P1P2 (three libraries per strain) produced a total of
about 535 million reads (about 90 million per library), of which
around 96% passed the Illumina filtering step (Table S1). Raw
sequencing data were submitted to the European Nucleotide
Archive (ENA) under the accession ERP105089. On average,
85% of the reads could be mapped to the published genome of
UK99 (Urban et al., 2016). About 88% of the 12,537 annotated
genes were expressed in each library. High similarity of read
abundance per genes was found among libraries with libraries
belonging to the same strain clustering together (Figure S2).
A differential gene expression analysis performed to determine
how differently P1P2 responded to tebuconazole as compared
to UK99, revealed that 4940 transcripts (39.4% of annotated
genes) had significantly different level of expression (q < 0.05).
Among those transcript, 649 were upregulated and 1214 were
downregulated (fold-change [FC] > 2) in tebuconazole-treated
P1P2 as compared to treated UK99. Gene ontology (GO)
term enrichment analysis showed that those genes generally
belonged in the same categories of “molecular function,” “cellular
component,” and “biological process” with only a higher count
for the downregulated genes (level 2; Figure S3). The differences
of gene expression of treated P1P2 ranged from up to 576
fold increase (FCUL_10778) and 32 fold decrease (FCUL_05061,
Table 1) as compared to treated UK99. All three CYP51s had
significantly different levels of expression (CYP51A: FC = 0.80,
q < 0.001; CYP51B: FC = 0.09, q = 0.038; CYP51C: FC = 0.11,
q = 0.02) but the magnitude of the fold-change was relatively
small. Of the 4940 differentially expressed among strain P1P2 and
UK99, 1408 were also differentially expressed in F. graminearum
PH-1 after a tebuconazole treatment (Becher et al., 2011) and 78
of them were mutually upregulated in both comparisons (Table 1
and Table S2). A total of 17 SNPs were found in the coding
regions of P1P2 transcripts when compared to the reference
UK99 genome with 12 of them resulting in amino acid changes
(Table 2 and Table S3).
Overexpression of FcABC1 Is Confirmed in
Tebuconazole-Treated Field Isolates
Among the most differentially expressed genes, the expression
levels of a subset of interesting genes were investigated using RT-
qPCR in order to validate the results of the RNA-Seq experiment
and to compare the expression of the treated samples to that
of the control samples (Figure 4). The detailed results of all
statistical tests are presented in Table S4. The expression fold
change measure for each gene in P1P2 and UK99 was of the
same order of magnitude when comparing the results from the
RNA-Seq experiment and the RT-qPCR assays (Figure S4). The
expression levels of CYP51A, B and C were all significantly
enhanced in both strains after treatment, but the slight significant
downregulation between treated samples observed in the RNA-
Seq experiment could not be confirmed by RT-qPCR (Figure 4).
Among the selected upregulated genes, the expression levels
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FIGURE 1 | Evaluation of the fitness parameters of the tebuconazole-adapted strain (P1P2) and its parental strain (UK99). Comparison between the strains was
based on (A) growth rate, (B) sporulation capacity, (C) pathogenicity on wheat ears with (treated) and without (ctrl) tebuconazole treatment, pathogenicity to (D)
wheat and (E) maize plantlets and (F) aggressiveness toward maize stalk. Error bars represent standard errors.
of FCUL_06717, FCUL_06718, FCUL_10778, and FCUL_11936
were all significantly higher in P1P2 after a tebuconazole
treatment than in any other samples. The expression pattern of
FCUL_03752 followed the same pattern as the previous genes
but the differences observed were not significant. No statistical
difference was found among samples in the case of FCUL_06826.
The three downregulated genes selected all presented a similar
pattern of expression with the treated UK99 strain showing the
highest expression levels.
The expression of all of these genes, except for CYP51s
and FCUL_06826, was subsequently analyzed on a set of F.
culmorum strains considered to be either triazole-sensitive or
resistant (Figure 5). Overall, the gene expression levels appeared
to be more consistent and homogenous among the sensitive
strains than among the resistant strains and differences between
the control and the treated samples were therefore usually
significant for the sensitive strains. As for UK99 (Figure 4),
the sensitive strains generally responded with an upregulation
of the tested genes after treatment, whereas it was not always
the case for the resistant strains. For instance, the expression
pattern of FCUL_06324 was significantly upregulated in UK99
after treatment (Figure 4) and it was also the case for all sensitive
strains (Figure 5). Yet, the same gene was slightly downregulated
in P1P2 after treatment (Figure 4) but its expression was highly
variable among resistant strains, resulting in no overall statistical
differences between control and treated samples (Figure 5). The
expression pattern of FCUL_06717, characterized by a higher
overexpression of the transcript in the resistant strain than
in the sensitive strain, was the only one that was consistent
with the pattern observed for both P1P2 and UK99 (Figure 4).
Furthermore, statistical analysis using Tukey’s test confirmed
that the resistant strains confronted to tebuconazole had the
highest level of expression for FCUL_06717, followed by the
treated sensitive strains whereas the expression of the gene in
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FIGURE 2 | Comparison of tebuconazole sensitivity of the adapted strain
(P1P2) with its parental strain (UK99) in a microtiter plate assay. (A) Strains
inoculated in triplicates in potato dextrose broth amended with increasing
concentrations of tebuconazole. (B) Absorbance readings (620 nm) were used
to quantify fungicide sensitivity with a four-parameter logistic regression. Error
bars represent the standard deviation between the means of three
independent assays.
the untreated controls in both groups of strains were equally
lower (Figure 5). However, the average expression fold-change
observed when comparing the treated resistant strains to the
treated sensitive strains (FC = 3.71; Figure 5) was considerably
lower than between P1P2 and UK99 (FC = 26.8; Figure 4).
The pattern of expression of other genes (FCUL_03754,
FCUL_06718, FCUL_10778, and FCUL_11936) did not support
their consistent involvement in the resistance naturally occurring
in the field (Figure 5).
Resistance Is Not the Result of a Sequence
Modification in FcABC1
FcABC1 and its flanking regions were sequenced for the adapted
and parental strains in order to identify potential modifications
that might have occurred in the gene’s regulatory regions that
would be responsible of the higher level of observed after azole
treatment in the adapted strain. No differences were found in the
415 bp region upstream of the start codon of FcABC1 neither
between the two strains nor among the field isolates. The 448
nucleotides sequenced downstream of the stop codon, did not
reveal any differences either between P1P2 and UK99. The gene
itself was 4,569 bp long compared with 4,580 bp and 4,584 bp in F.
graminearum (FGSG_04580) and F. pseudograminearum (Aoki
& O’Donnell) (FSPE_06011). The sequence of UK99 had only
one nucleotide difference with the one of F. culmorum CS7071 at
position 3090. This mutation at the third position of the codon
between C (UK99) and T (CS7071), is however silent, leading
to a leucine at amino acid position 1030. Nevertheless, there
was no amino acid difference between the parental and adapted
strains in this region. All three sequences for UK99/P1P2 were
stored in GenBank under Accession No. KX601158. Phylogeny
showed that FcABC1 has homologs in multiple other fungal
species/genera (Figure S5).
DISCUSSION
The baseline sensitivity of F. culmorum to triazoles has been
previously shown to be quite stable over time, although more
resistant strains could be observed in the field. As a result, it
has been postulated that the acquisition of resistance could come
at a cost preventing the development of a resistant population
in the field (Hellin et al., 2016b). Indeed, an in vitro fitness
penalty had been observed by Serfling and Ordon (2014) for a
F. culmorum strain adapted to tebuconazole. In order to verify
this hypothesis an adaptation method, inspired by previous
methodologies (Becher et al., 2010; Serfling and Ordon, 2014),
was performed on the sensitive strain UK99. This method had
the advantage of bypassing the use of mutation inducers, such
as UV light, that introduce random mutation in the genome.
Instead, it applied a tebuconazole-specific selective pressure on
the strain that better mimicked what would naturally occur
in the field. Remarkably, this procedure allowed producing
and selecting a F. culmorum strain (P1P2) that was not only
more resistant to tebuconazole than its parental strain, but
with almost no other phenotypic changes. Indeed, all fitness
parameters tested (sporulation, growth and pathogenicity) were
practically identical between the two strains. Moreover, in vitro
experiments showed that not only was that strain more resistant
to tebuconazole (by about 10-fold) and every other tested DMI,
but also that the acquired resistance was specific to this fungicide
group. Their common mode of action enable fungi to develop
cross-resistance to these molecules and this phenomenon has
been often reported for Fusarium spp. (Yin et al., 2009; Becher
et al., 2010; Serfling and Ordon, 2014; Spolti et al., 2014) as well as
for other fungi such as Ustilago maydis (DC.) Corda, Sclerotinia
homoeocarpa (F.T. Bennett), Rhynchosporium secalis ([Oudem.]
Davis) and Zymoseptoria tritici ([Desm.] Quaedvlieg & Crous)
(Wellmann et al., 1996; Hsiang et al., 1997; Robbertse et al., 2001;
Cools and Fraaije, 2012). The adapted strain even seemed to be a
little less affected by a curative tebuconazole treatment applied on
infected wheat ears compared with the wild-type strain, although
this difference was not statistically supported. In their attempt to
adapt in vitro an F. culmorum strain to azoles, Serfling and Ordon
(2014) produced a strain that had a reduced in vitro fitness,
but was insensitive to azole treatment in planta compared with
its parental strain. Taking together, these observations supports
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FIGURE 3 | Qualitative cross-resistance comparison between UK99 and P1P2 to a variety of fungicides with different modes of action on PDA medium. Each image
is a 2 × 2 cm square surrounding the inoculation point after 7 days of growth.
the possibility that the repetitive use of triazoles in the field
could naturally give rise to competitive F. culmorum strains with
triazole resistance.
Taking advantage of the similar genetic background of UK99
and P1P2, we compared their transcriptome after tebuconazole
treatment to detected targets with a potential role in DMI
resistance. Surprisingly, the transcriptomic differences observed
between the 2 treated strains were drastically different with
significant differences observed for almost 40% of the genes in
the currently annotated version of F. culmorum genome (Urban
et al., 2016). Surprisingly, this difference in gene expression was
even higher than what was observed for F. graminearum PH-1
treated or not with tebuconazole (Becher et al., 2011). Several
authors have used different genome wide approaches to detect
gene targets involved in F. graminearum response or sensitivity
to triazoles (Liu et al., 2010; Becher et al., 2011; Talas et al.,
2016). Interestingly, none of the genes highlighted in their study
were present among the most differentially regulated genes (with
homologs in F. graminearum) between the treated F. culmorum
strains UK99 and P1P2, indicating the complementarity of the
studies.
Only 12 non-synonymous mutations were detected in the
coding regions of P1P2 genes as compared to the reference
F. culmorum genome and none of them occurred in the
CYP51 genes. In a genome-wide association study, Talas et al.
(2016) detected 51 genes with SNPs that could be linked to
propiconazole sensitivity over 220 strains of F. graminearum.
None of those SNPs occurred in the CYP51 genes nor were
commonwith the SNPs in F. culmorum homologs observed in the
present study. Moreover, no nucleotide changes leading to amino
acid substitutions were found in the CYP51B gene of the more
resistant F. culmorum field isolates investigated in this study (data
not shown). Adding to the fact that mutations in CYP51s were
not linked to the azole sensitivity of F. graminearum field isolates
in other studies (Yin et al., 2009; Talas and McDonald, 2015)
and that mutations in CYP51s might only be associated with
resistance to a subset of DMI fungicides as observed for Z. tritici
(Cools and Fraaije, 2012), these results suggest that mutations in
CYP51s do not play a role in the resistance of the DMI-adapted
F. culmorum strain P1P2.
The overexpression of CYP51 genes is a common resistance
mechanism that has been reported for numerous species (Lucas
et al., 2015; Ziogas and Malandrakis, 2015) and can yield to
pan-azole resistant phenotypes (Cools et al., 2012). Indeed, the
expression of all CYP51s was increased after the tebuconazole
treatment. Although, this overexpression was found to be
significantly different between the two strains in the RNA-Seq,
the fold-change was lower than two and the increase was always
in favor of the sensitive strain UK99. Moreover, qPCR analysis
did not confirm this difference. Other studies on F. graminearum
have also highlighted the upregulation of the CYP51 genes after a
triazole treatment (Yin et al., 2009; Liu et al., 2010; Becher et al.,
2011) but no relation with the level of triazole sensitivity could be
observed (Yin et al., 2009). Therefore, the upregulation of sterol
biosynthetic genes is not likely to be a part of the mechanism
developed by P1P2 to resist to DMI fungicides.
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TABLE 1 | Top 20 genes with the highest change of gene expression of P1P2 as compared to UK99 when subjected to tebuconazole.
Fc gene IDa Fg gene IDb Old Fg gene IDc Blast description Log2(FC)
d q-value
TOP 20 UPREGULATED GENES IN P1P2
FCUL_10778 FgramPH1_01t25277 FGSG_07642 Pentalenolactone D synthase 9.17 <0.001
FCUL_05462 FgramPH1_01t12719 FGSG_03372 Hypothetical protein 6.54 <0.001
FCUL_08942 FgramPH1_01t20959 FGSG_10990 Nonribosomal peptide synthetase 6.26 0.007
FCUL_06718 FgramPH1_01t15629 FGSG_04581 Transcription factor 5.86 <0.001
FCUL_11938 FgramPH1_01t27981 FGSG_09076 Hypothetical protein 5.66 0.007
FCUL_06717 FgramPH1_01t15627 FGSG_04580 ATP binding cassette transporter 5.05 <0.001
FCUL_03752 FgramPH1_01t06339 FGSG_02641 Glucose transporter rco-3 4.7 0.004
FCUL_06619 FgramPH1_01t15371 FGSG_12251 Hypothetical protein 4.65 0.01
FCUL_11936 FgramPH1_01t06405 FGSG_02672 Ent-kaurene oxidase 4.59 <0.001
FCUL_05234 FgramPH1_01t12209 FGSG_03164 Hypothetical protein 4.26 <0.001
FCUL_09162 FgramPH1_01t21537 FGSG_11228 GMC oxidoreductase 4.23 <0.001
FCUL_03997 FgramPH1_01t09381 FGSG_15034 Hypothetical protein 4.19 <0.001
FCUL_06808 FgramPH1_01t15839 FGSG_04667 α-ketoglutarate-dependent sulfonate
dioxygenase
4.04 0.01
FCUL_12351 FgramPH1_01t15901 FGSG_16066 Hypothetical protein 4.01 <0.001
FCUL_05043 FgramPH1_01t11775 FGSG_16357 Phosphoethanolamine
n-methyltransferase 3
3.97 <0.001
FCUL_06826 FgramPH1_01t15935 FGSG_16060 Alkanesulfonate monooxygenase 3.94 <0.001
FCUL_11949 FgramPH1_01t28003 FGSG_09066 Hydrophobin 3 precursor 3.77 <0.001
FCUL_12358 FgramPH1_01t15903 FGSG_11577 Hypothetical protein 3.74 <0.001
FCUL_08941 FgramPH1_01t20957 FGSG_10989 Short-chain dehydrogenase reductase 3.67 0.002
FCUL_12331 FgramPH1_01t08795 #N/A Hypothetical protein 3.54 <0.001
TOP 20 DOWNREGULATED GENES IN P1P2
FCUL_05061 FgramPH1_01t11819 FGSG_03001 Hypothetical protein −5 <0.001
FCUL_11186 FgramPH1_01t26259 FGSG_15560 Hypothetical protein −4.92 <0.001
FCUL_02780 FgramPH1_01t06451 FGSG_02694 Spherulin 1b partial −4.74 <0.001
FCUL_06652 FgramPH1_01t15459 FGSG_04503 α/β hydrolase −4.62 <0.001
FCUL_11523 FgramPH1_01t27023 FGSG_09463 Related to Rtm1p −4.4 < 0.001
FCUL_10992 FgramPH1_01t25819 FGSG_07852 Short-chain dehydrogenase reductase −4.4 <0.001
FCUL_07989 FgramPH1_01t18803 FGSG_05807 Platelet-activating factor acetylhydrolase −4.39 0.007
FCUL_05569 FgramPH1_01t12957 FGSG_12425 Hypothetical protein −4.33 <0.001
FCUL_05879 FgramPH1_01t13679 FGSG_03775 Hypothetical protein −4.31 <0.001
FCUL_09092 FgramPH1_01t21365 FGSG_11162 α/β hydrolase −4.14 0.041
FCUL_02116 FgramPH1_01t04887 FGSG_02023 Hypothetical protein −4.13 <0.001
FCUL_09505 FgramPH1_01t22379 FGSG_06479 Hypothetical protein −4.12 <0.001
FCUL_05374 FgramPH1_01t12533 #N/A Hypothetical protein −4.08 <0.001
FCUL_06662 FgramPH1_01t15493 FGSG_04516 Kinase-like protein −4.06 <0.001
FCUL_05450 FgramPH1_01t12693 #N/A Transcriptional regulatory protein −4.02 <0.001
FCUL_09693 FgramPH1_01t22845 FGSG_06656 Sphingoid long-chain base transporter
rsb1
−4.01 <0.001
FCUL_03573 FgramPH1_01t08257 FGSG_10500 Pyridine nucleotide-disulfide
oxidoreductase family
−3.99 <0.001
FCUL_03340 FgramPH1_01t07709 #N/A Hypothetical protein −3.97 < 0.001
FCUL_06324 FgramPH1_01t14693 FGSG_04188 Related to major facilitator (MFS1)
transporter
−3.95 <0.001
FCUL_08886 FgramPH1_01t20827 FGSG_10930 Hypothetical protein −3.89 < 0.001
Table sorted by Log2 fold change.
aGene ID in the F. culmorum (UK99) genome annotation (Urban et al. 2016). Bold genes were also found to be upregulated in F. graminearum (PH-1) after a tebuconazole treatment
(Becher et al., 2011).
bGene id in the most recent version of F. graminearum (PH-1) genome annotation (King et al., 2015).
cGene id in the previous version of F. graminearum (PH-1) genome annotation (Cuomo et al., 2007).
dFold change of expression between tebuconazole-treated P1P2 and UK99 strains.
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TABLE 2 | Single nucleotide polymorphism (SNP) found in the coding regions of
P1P2 transcripts when compared to the reference UK99 genome.
Gene ID Codon changea Effectb Blast description
FCUL_00816 gaG/gaT E7D Small nuclear ribonucleoprotein
FCUL_02215 gGc/gAc G450D Feruloyl esterase b
FCUL_02467 cCa/cGa P757R Polyketide synthase
FCUL_03745 Cat/Gat H240D Unnamed protein product
FCUL_05178 atG/atC M37I Hypothetical protein
FCUL_05369 tTc/tCc F716S Transcription factor
FCUL_05892 gCt/gTt A474V Transcription factor
FCUL_06062 Cat/Gat H185D Heterokaryon incompatibility
FCUL_06890 Tct/Cct S118P Hypothetical protein
FCUL_06925 acT/acG – Endo-beta-glucanase
FCUL_09267 acC/acA – Hypothetical protein
FCUL_09409 gGg/gAg G109E Hypothetical protein
FCUL_10796 gaC/gaT – Hypothetical protein
FCUL_12334 gGt/gAt G317D Hypothetical protein
FCUL_12417 aGg/aAg R213K Hypothetical protein
aPosition of the SNP (in upper case) in the codon.
bPredicted amino acid change resulting from SNP.
After the investigation of the expression profiles of multiple
genes that were significantly more expressed in the resistant
strain P1P2 upon treatment, FcABC1 (FCUL_06717) appeared as
a suitable candidate to explain the difference in DMI sensitivity
between the two strains. Moreover, this gene was also shown
to be upregulated in F. graminearum after a tebuconazole
treatment (Becher et al., 2011). The gene demonstrated an
expression level about 30-fold higher in P1P2 than the in
parental strain after tebuconazole treatment. This difference in
expression could be verified on field strains harboring distinct
azole sensitivity levels, with the resistant strains showing a higher
overexpression of the transporter than the sensitive strains upon
tebuconazole treatment. Overexpression of a transporter is a
common feature developed by fungi in response to triazole
pressure (Ziogas and Malandrakis, 2015). For example, in S.
homoeocarpa, the pathogen causing dollar spot on turf grass, the
overexpression of two ABC transporters, ShPDR1 and ShatrD,
was linked to practical field resistance (Hulvey et al., 2012;
Sang et al., 2015). The modulation of transporter expression
can be due to mutations or indels occurring in the gene’s
regulatory regions. A 519 bp insert has, for example, been
linked with the overexpression of an MFS (Major facilitator
superfamily) transporter conferring multidrug resistance in Z.
tritici (Omrane et al., 2015). Yet, no difference could be found
in the upstream region of FcABC1, neither in the gene itself nor
in the 448 bp following its stop codon, suggesting that another
regulatory mechanismmight be involved, such as overexpression
of a transcription factor or even an epigenetic modification.
Interestingly, a zinc finger transcription factor (FCUL_06718)
located next to FcABC1 in the genome of UK99, showed the
same difference of expression as FcABC1 between the parental
and resistant strain. Unfortunately this pattern of expression was
not completely matched by the expression profile observed for in
the resistant and sensitive field strains.
The protein sequence of FcABC1 showed high homology
with multiple proteins present in different species of Fusarium,
including F. graminearum (i.e., FgABC3) in which it has been
shown to be implicated in azole sensitivity (Abou Ammar
et al., 2013), as well as in other genera such as Trichoderma
and Colletotrichum. Therefore, it can be anticipated that
overexpression of these homologous proteins could enhance
resistance in the corresponding species. In line with our findings,
the sensitivity levels to the various DMI fungicides of F.
graminearum mutants lacking FgABC3 were shown to increase
while no change in sensitivity were observed with regard to
selected strobilurin, amines, SDHI (succinate deshydrogenase
inhibitors), quinone, N-phenyl carbamate or thiocarbamate
(Abou Ammar et al., 2013). However, FgABC3mutants produced
by Gardiner et al. (2013) were found to be more sensitive to
benalaxyl, a phenylamide fungicide targeting RNA polymerase I,
for which the resistance mechanism remains unknown (FRAC,
2018). In the present study, the resistant strain was found to be
less sensitive to pyrimethanil, an anilino-pyrimidine fungicide
interfering with methionine biosynthesis (FRAC, 2018). This
kind of negative cross-resistance among active ingredients has
been reported in some drug/microbe systems (Pál et al., 2015).
Functional analysis of FcABC1 by gene disruption had previously
revealed its role in wheat and barley infection by F. culmorum
(Skov et al., 2004). Similarly, F. graminearum mutants lacking
the FcABC1 homolog (FgABC3) showed a reduced virulence on
wheat altough the growth rate of FgABC3 mutants subjected to
various defensive plant metabolites appeared to be unaffected
(Abou Ammar et al., 2013; Gardiner et al., 2013). Interestingly, in
F. sambucinum (Fuckel), the FcABC1 homologous transporter is
necessary to protect the pathogen against rishitin, a phytoalexin
present in potato tubers (Fleissner et al., 2002). As it would be
expected from PDR transporters, the specificity of FcABC1 and
homologs might therefore not be restricted to a single chemical
family such as DMI fungicides.
The field strains used in this study exhibited highly contrasted
sensitivity levels to triazoles but it has been shown that DMI
fungicides usually give rise to a more continuous distribution
of resistance degree in the field (Lucas et al., 2015). Therefore,
the implication of FcABC1 in triazole resistance might only be
linked to a particular phenotype of highly resistant strains and
other processes could be involved in F. culmorum resistance,
as it has been seen in other fungi such as Z. tritici (Cools and
Fraaije, 2012). As fungal populations evolve, among other things,
in response to fungicide pressure, it is possible that different
types of mechanisms will develop in the future. Detoxification of
the fungicide molecules is the less frequently reported resistance
mechanism. In this study, FCUL_06826, FCUL_10778, and
FCUL_11936, enzymes with potential degradation capacity were
investigated but their implication in DMI resistance was not
confirmed in F. culmorum field strains, even though the homolog
of FCUL_11936 has also been shown to be upregulated in
F. graminearum upon tebuconazole treatment (Becher et al.,
2011). Mechanisms of detoxification of drugs are well known
in herbicide resistance and usually involve enzymes such as
cytochrome P450 monooxygenase, glycosyl transferase and
glutathione S-transferase (Yu and Powles, 2014). Only a few cases
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FIGURE 4 | Expressions of selected genes in the resistant strain (P1P2) and in the wild-type strain (UK99) of Fusarium culmorum with (treated) or without (untreated)
tebuconazole treatment (2.5 mg/L). The arrow next to the gene ID indicates whether the gene transcription was up or downregulated in the RNA-Seq experiment.
“FC” reports the fold-change of expression measured between the P1P2 and UK99 when treated. The P-value represents the significance level of the interaction
factor between strains and treatments in the ANOVA. Different letters on top of bars correspond to significantly different levels of expression determined by Tukey’s
test, performed when the interaction was significant. Error bars represent standard errors.
of resistance by fungicide degradation have been reported such as
the degradation of kresoxym-methyl by an esterase in Venturia
inequalis (Jabs et al., 2001) or of fenhexamid by a cytochrome
P450 monooxygenase in Botrytis cinerea (Leroux et al., 2002).
Understanding the current and future challenges of resistance
development is mandatory to preserve the field efficacy
of triazoles in the management of Fusarium spp. related
diseases and the discovery of molecular mechanisms underlying
resistance will improve the management strategies. Ultimately,
new targets for the chemical control arise from mechanistic
studies and might one day lead to the development of new
fungicides that circumvent the existing resistance.
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FIGURE 5 | Expressions of selected genes in triazole-sensitive (S1 = MBC 6020, S2 = MBC 7603 and S3 = MBC 7964) and triazole-resistant (R1 = MBC 190,
R2 = MBC 7555, and R3 = CRA PAV ER 1998) strains of Fusarium culmorum with (treated or T) or without (untreated or nT) tebuconazole treatment (2.5 mg/L). The
arrow next to the gene ID indicates whether the gene transcription was up or downregulated in the RNA-Seq experiment. “FC” reports the fold-change of expression
measured between the resistant and sensitive strains when treated. The P-value represents the significance level of the interaction factor between resistance levels
and treatments in the linear mixed model. In the top left frame, group (e.g., S-nT) with different letters associated to them have significantly different levels of
expression as determined by Tukey’s test, performed when the interaction was significant. Error bars represent standard errors.
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Figure S1 | Summary of the screening procedure to select a triazole-adapted
phenotype from F. culmorum strain UK99. (A) Conidia solutions point-inoculated
on PDA amended with 1 mg/l of tebuconazole incubated for 4 days. (B) Sensitivity
(EC50) of the strains to tebuconazole measured by microtiter plate assays (C)
Growth on PDA after 4 days. (D) Pathogenicity to wheat seedlings grown on SNA
in test tubes measured by growth retardation and symptom severity. (E)
Pathogenicity to wheat ears of point-inoculated conidia suspension with or
without a curative tebuconazole treatment. Error bars are SEM.
Figure S2 | Comparison of transcript abundances among each library. (A) Heat
map showing the hierarchical clustering (complete linkage method) of the
Euclidian distance between transcript abundance of each library. (B) Score plot of
the principal component analysis performed on the transcript abundance matrix of
all libraries.
Figure S3 | Functionnal characterization of the differentially genes expressed (FC
> 2 and q < 0.05) in the treated resistant strain (P1P2) as compared to its treated
parental strain (UK99). The gene onthology terms (level 2) for the 469 up- and
1214 down-regulated genes plotted are sorted into three categories for biological
processes, cellular component and molecular function.
Figure S4 | Expression fold-change of select genes between the resistant strain
(P1P2) and the sensitive strain (UK99) both treated with tebuconazole in the
RNA-Seq experiment as compared to the RT-qPCR assays.
Figure S5 | Neighbor joining phylogenetic tree representing evolutionary
relationships between F. culmorum ABC1 and other selected ABC transporters
protein sequences (N = 34). Entries in bold correspond to ABC transporters
known for their implication in demethylation inhibitor (DMI) resistance in other plant
pathogenic fungi. Sequences from F. graminearum are in red. Sequences were
aligned using MUSCLE and phylogenetic relationships were then calculated using
the neighbor joining method with the default parameters implemented in MEGA6.
Branch support, obtained with 1,000 bootstrap iterations, is indicated by the
relative size of the black dot on the corresponding branch.
Table S1 | Metrics summarizing the transcriptome sequencing and alignment to
UK99 genome of each library (3) belonging to the tebuconazole-treated strains of
UK99 and P1P2.
Table S2 | Detailed list of all transcripts mutually upregulated both in this study
(treated-Fc_P1P2 vs treated-Fc_UK99) and in Becher et al. (2011)
(treated-Fg_PH1 vs untreated-Fg_PH1).
Table S3 | Detailed list of all single nucleotide polymorphisms (SNPs) found when
comparing P1P2 transcriptome to the reference UK99 genome.
Table S4 | Statistical significance levels (P-values) of the parameters used to
explain gene expression differences observed in the RT-qPCR experiments.
Table S5 | List primers used for quantification of transcript level of candidate
genes.
Table S6 | List of primers used for amplification and sequencing of FcABC1.
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